XEN45
1924-701-007
Phase 3 other completed
Quick answer
XEN45 for Glaucoma is a Phase 3 program (other) at Allergan Pharmaceuticals International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allergan Pharmaceuticals International Limited
- Indication
- Glaucoma
- Phase
- Phase 3
- Modality
- other
- Status
- completed